Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 175

Sort by

Sort Order Select

Journal Articles

miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms

Blood (2021) 137 (14): 1905–1919.

https://doi.org/10.1182/blood.2020009088

Published: 2021

Includes: Supplemental data

Journal Articles

Knowledge Transfer between Artificial Neural Networks for Different Multicolor Flow Cytometry Protocols Improves Classification Performance for Rare B-Cell Neoplasm Subtypes

Nanditha Mallesh, Max Zhao, Franz Elsner, PhD, Hannes Lueling, PhD, Richard Schabath, PhD, Claudia Haferlach, MD, Torsten Haferlach, MD, Peter Krawitz, MD, Wolfgang Kern, MD

Blood (2019) 134 (Supplement_1): 2094.

https://doi.org/10.1182/blood-2019-130483

Published: 2019

Journal Articles

Igcaller: Reconstructing the Rearranged Immunoglobulin Gene in Lymphoid Neoplasms from Whole-Genome Sequencing Data

Ferran Nadeu, Rut Mas-de-les-Valls, Romina Royo, Alba Navarro, Sílvia Beà, Junyan Lu, PhD, Alfredo Rivas-Delgado, MD, Neus Villamor, Silvia Martín, Marta Aymerich, Tycho Baumann, Julio Delgado, Dolors Colomer, PhD, Xose S Puente, Thorsten Zenz, MD, Peter J Campbell, Francesco Maura, MD, Elias Campo

Blood (2019) 134 (Supplement_1): 3023.

https://doi.org/10.1182/blood-2019-130071

Published: 2019

Journal Articles

Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R 2 ) in Primary Effusion Lymphoma in Patients with or without HIV

Kathryn Lurain, MDMPH, Ramya Ramaswami, MBBS,MPH, Anaida Widell, RN, Irene Ekwede, RN, Jomy George, PharmD, Maryalice Stetler-Stevenson, MD PhD, Mark Raffeld, MD, Constance M. Yuan, MD PhD, Joseph Ziegelbauer, PhD, Frank Maldarelli, MD PhD, William D. Figg, PharmD, Cody Peer, PhD, Seth M. Steinberg, PhD, Denise Whitby, Thomas S. Uldrick, MD MS, Robert Yarchoan, MD

Blood (2019) 134 (Supplement_1): 4096.

https://doi.org/10.1182/blood-2019-122070

Published: 2019

Journal Articles

Survival Outcomes in Patients with Waldenström Macroglobulinemia/ Lymphoplasmacytic Lymphoma According to MYD88 Mutation Status

Agrima Mian, MBBS, MD, Albert Aboseif, DO, Wei Wei, MS, Rajshekhar Chakraborty, MD, Jack Khouri, MD, Joslyn Rudoni, PharmD, Allison M. Winter, MD, Sonam Patel, MD, Deepa Jagadeesh, MDMPH, Robert M. Dean, MD, Brad Pohlman, MD, Stephanie Berg, DO, James R. Cook, MD PhD, Brian T. Hill, MD, Alex V. Mejia Garcia, MD

Blood (2019) 134 (Supplement_1): 5248.

https://doi.org/10.1182/blood-2019-130396

Published: 2019

Journal Articles

The Grey Zone: Characterization of Aggressive High-Grade B-Cell Malignancy with TdT Expression and IGH/BCL2 and MYC Rearrangement

Shonali Midha, MD, Julio C. Chavez, MD, Hayder Saeed, MD, Celeste Bello, MD, Farhad Khimani, MD, Silvia Tse Bunting, MD MSc, Bijal Shah, MD

Blood (2019) 134 (Supplement_1): 5347.

https://doi.org/10.1182/blood-2019-130721

Published: 2019

Journal Articles

Durvalumab (Anti PD-L1) As Monotherapy or in Combination Therapy for Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL): A Subgroup Analysis from the Phase 1/2 Fusion NHL-001 Global Multicenter Trial

Blood (2019) 134 (Supplement_1): 5320.

https://doi.org/10.1182/blood-2019-124102

Published: 2019

Journal Articles

Mitochondrial Genome-Derived Mc-COX2 with Novel Characteristics Predicts Prognosis of Patients with Chronic Lymphocytic Leukemia

Hui Jin, Jianyong Li, MD, Zijuan Wu, Handong Sun, Yi Xia, Jianxin Fu, MD PhD, Lei Fan, MD PhD, Wei Xu, MD PhD, Li Wang, MD

Blood (2019) 134 (Supplement_1): 4284.

https://doi.org/10.1182/blood-2019-124609

Published: 2019

Journal Articles

An Artificial Neural Network Providing Highly Reliable Decision Support in a Routine Setting for Classification of B-Cell Neoplasms Based on Flow Cytometric Raw Data

Wolfgang Kern, MD, Franz Elsner, PhD, Max Zhao, Nanditha Mallesh, Richard Schabath, PhD, Claudia Haferlach, MD, Peter Krawitz, MD, Hannes Lueling, PhD, Torsten Haferlach, MD

Blood (2019) 134 (Supplement_1): 886.

https://doi.org/10.1182/blood-2019-130374

Published: 2019

Journal Articles

Prospective Long-Term Follow-up after First-Line Subcutaneous Cladribine Treatment in Patients with Hairy Cell Leukemia. a Study of the SAKK (Swiss Group for Clinical Cancer Research)

Rudolf A. Benz, MD, Kornelius Arn, MD, Martin Andres, Thomas Pabst, MD PhD, Urban Novak, Felicitas Hitz, MD, Reinhard Zenhäusern, Yves Chalandon, MD PhD, Ulrich Mey, MD, Sabine Blum, Daniel Rauch, Willy Nettekoven, Nathan Cantoni, MD, Mario Bargetzi, MD, Alix O'Meara, MD, Andreas Lohri, MD, Simona Berardi, PhD BSc, Qiyu Li, Georg Stussi, MD

Blood (2018) 132 (Supplement 1): 2875.

https://doi.org/10.1182/blood-2018-99-114301

Published: 2018

Journal Articles

A Novel Oral Histone Deacetylase Inhibitor Chidamide Is Highly Effective and Well-Tolerated in Adult Early T-Cell Precursor and Ph-like Acute Lymphoblastic Leukemia

Hongsheng Zhou, MD PhD, Ya Gao, MD, Qiang Wang, Rui Cao, Zhongxin Zhen, Qiuli Li, Dainan Lin, Linlin Zhou, Changxin Yin, Han He, Xiaoli Liu, Bing Z Carter, PhD, Qifa Liu, MD

Blood (2018) 132 (Supplement 1): 4011.

https://doi.org/10.1182/blood-2018-99-113712

Published: 2018

Journal Articles

Splenic B-Cell Lymphoma/Leukemia, Unclassifiable in Japan

Takaharu Suzuki, MD, Hiroaki Miyoshi, MD PhD, Keisuke Kawamoto, MD PhD, Joji Shimono, MD PhD, Jun Takizawa, MD PhD, Masao Seto, MD PhD, Koichi Ohshima, MD PhD

Blood (2018) 132 (Supplement 1): 5301.

https://doi.org/10.1182/blood-2018-99-113239

Published: 2018

Journal Articles

Clinical Characteristics and Outcomes of an Analysis of a Single Institution Experience of the 2017 World Health Organization (WHO) Classification of Post-Transplant Lymphoproliferative Disorders (PTLD)

Thomas M. Habermann, MD, Angelo Fama, MD, Kay M. Ristow, BS, Matthew J. Maurer, MS, William R. Macon, MD, Stephen M. Ansell, MD PhD, Nabila Nora Bennani, MD, Yogish C Kudva, MBBS, Randall C. Walker, MD, Kimberly D. Watt, Thomas R. Schwab, MD, James R. Cerhan, MD PhD, Rebecca L King, MD

Blood (2018) 132 (Supplement 1): 456.

https://doi.org/10.1182/blood-2018-99-113667

Published: 2018

Journal Articles

Clinical Implications of MYD88 and CXCR4 in Patients with Waldenström's Macroglobulinemia

Martina Divoka, Tomas Pika, MD PhD, Lenka Krupkova, Monika Orviska, Romana Janska, Jiri Minarik, MD PhD, Tomas Papajik, MD prof

Blood (2018) 132 (Supplement 1): 5314.

https://doi.org/10.1182/blood-2018-99-112855

Published: 2018

Journal Articles

Concomitant BRAF Mutation in Hairy Cell Leukemia and Papillary Thyroid Cancer

Shehab Mohamed, MD, Mohamed A Yassin, MBBS, MSc, Abdulqadir Jeprel Nashwan, BSN, MSN, RN, CBT-HMS, Halima El Omri, Firyal Ibrahim, MB, CHB, PhD, Susana El akiki, PhD

Blood (2018) 132 (Supplement 1): 5140.

https://doi.org/10.1182/blood-2018-99-116084

Published: 2018

Journal Articles

Classical Hodgkin Lymphoma Patients Have an Increased Incidence of Idiopathic Acquired Aplastic Anemia

Taylor Linaburg, BSc, Adam R. Davis, MD, Noelle V. Frey, MD, Daniel J. Landsburg, MD, Stephen J. Schuster, MD, Jakub Svoboda, MD, Yimei Li, PhD, Yuliya Borovskiy, MS, Timothy S. Olson, MD PhD, Adam Bagg, MD, Elizabeth O. Hexner, MD MS, Daria V. Babushok, MD PhD

Blood (2018) 132 (Supplement 1): 5098.

https://doi.org/10.1182/blood-2018-99-110032

Published: 2018

Journal Articles

The First 100 Cases of Epstein-Barr Virus-Positive Mucocutaneous Ulcers

Ryan B. Sinit, David M. Aboulafia, MD, Russell K. Dorer, MD PhD

Blood (2018) 132 (Supplement 1): 5340.

https://doi.org/10.1182/blood-2018-99-110278

Published: 2018

Journal Articles

Distribution of Lymphomas in Mexico: A Descriptive Study

Alejandro Garcia-Horton, MD, Adrian Carballo-Zarate, Lizbeth Palma-Berre, Patricia Ramos-Salazar, Rogelio Sanchez-Verin-Lucio, Jorge Valenzuela-Tamariz, Lourdes Molinar-Horcasitas, Alejanda Zarate-Osorno, Alejandro Lazo-Langner, MD MSc

Blood (2017) 130 (Supplement 1): 2127.

https://doi.org/10.1182/blood.V130.Suppl_1.2127.2127

Published: 2017

Journal Articles

Whole Genome Sequencing in Hairy Cell Leukemia-Variant (HCL-v) and Splenic Marginal Zone Lymphoma (SMZL)

Torsten Haferlach, MD, Niroshan Nadarajah, Manja Meggendorfer, PhD, Claudia Haferlach, MD, Wolfgang Kern, MD

Blood (2017) 130 (Supplement 1): 4003.

https://doi.org/10.1182/blood.V130.Suppl_1.4003.4003

Published: 2017

Journal Articles

Germinal Center Program De-Synchronization and Intra-Patient Heterogeneity in Follicular Lymphoma B-Cells Revealed By Integrative Single-Cell Analysis

Pierre Milpied, PhD, Inaki Cervera-Marzal, Lionel Spinelli, PhD, Marie-Laure Mollichella, Bruno Tesson, Bertrand Nadel, PhD

Blood (2017) 130 (Supplement 1): 41.

https://doi.org/10.1182/blood.V130.Suppl_1.41.41

Published: 2017

NARROW

miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms

Knowledge Transfer between Artificial Neural Networks for Different Multicolor Flow Cytometry Protocols Improves Classification Performance for Rare B-Cell Neoplasm Subtypes

Igcaller: Reconstructing the Rearranged Immunoglobulin Gene in Lymphoid Neoplasms from Whole-Genome Sequencing Data

Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R 2 ) in Primary Effusion Lymphoma in Patients with or without HIV

Survival Outcomes in Patients with Waldenström Macroglobulinemia/ Lymphoplasmacytic Lymphoma According to MYD88 Mutation Status

The Grey Zone: Characterization of Aggressive High-Grade B-Cell Malignancy with TdT Expression and IGH/BCL2 and MYC Rearrangement

Durvalumab (Anti PD-L1) As Monotherapy or in Combination Therapy for Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL): A Subgroup Analysis from the Phase 1/2 Fusion NHL-001 Global Multicenter Trial

Mitochondrial Genome-Derived Mc-COX2 with Novel Characteristics Predicts Prognosis of Patients with Chronic Lymphocytic Leukemia

An Artificial Neural Network Providing Highly Reliable Decision Support in a Routine Setting for Classification of B-Cell Neoplasms Based on Flow Cytometric Raw Data

Prospective Long-Term Follow-up after First-Line Subcutaneous Cladribine Treatment in Patients with Hairy Cell Leukemia. a Study of the SAKK (Swiss Group for Clinical Cancer Research)

A Novel Oral Histone Deacetylase Inhibitor Chidamide Is Highly Effective and Well-Tolerated in Adult Early T-Cell Precursor and Ph-like Acute Lymphoblastic Leukemia

Splenic B-Cell Lymphoma/Leukemia, Unclassifiable in Japan

Clinical Characteristics and Outcomes of an Analysis of a Single Institution Experience of the 2017 World Health Organization (WHO) Classification of Post-Transplant Lymphoproliferative Disorders (PTLD)

Clinical Implications of MYD88 and CXCR4 in Patients with Waldenström's Macroglobulinemia

Concomitant BRAF Mutation in Hairy Cell Leukemia and Papillary Thyroid Cancer

Classical Hodgkin Lymphoma Patients Have an Increased Incidence of Idiopathic Acquired Aplastic Anemia

The First 100 Cases of Epstein-Barr Virus-Positive Mucocutaneous Ulcers

Distribution of Lymphomas in Mexico: A Descriptive Study

Whole Genome Sequencing in Hairy Cell Leukemia-Variant (HCL-v) and Splenic Marginal Zone Lymphoma (SMZL)

Germinal Center Program De-Synchronization and Intra-Patient Heterogeneity in Follicular Lymphoma B-Cells Revealed By Integrative Single-Cell Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only